Raymond James initiated coverage of Liquidia with an Outperform rating and $27 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LQDA:
- Court filing in United/FDA case may portend decision on Yutrepia, says Needham
- Liquidia reports Q2 EPS (37c), consensus (34c)
- Liquidia Corporation Reports Second Quarter 2024 Financial Results and Provides Corporate Update
- Liquidia Technologies call volume above normal and directionally bullish
- Liquidia files to sell 7.32M shares of common stock for holders
Questions or Comments about the article? Write to editor@tipranks.com